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Background: Epicardial adipose tissue (EAT), visceral fat depot of the heart, was found to be associated with
coronary artery disease in cardiac and non-cardiac patients. Platelet-to-lymphocyte ratio (PLR) and neutrophil-
to-lymphocyte ratio (NLR) were introduced as potential markers to determine inflammation in various disorders.
Recently, atherogenic index of plasma (AIP) was found to be closely associated with atherosclerosis in general
population. Waist circumference is commonly used to assess the risk factors in various metabolic disorders.
There has been a well known relation between inflammation and peripheral adipose tissue in diabetes mellitus.
However, the data regarding EAT and inflammation is scant in this population. Hence, we aimed to determine
the relationship between PLR, NLR, AIP, waist circumference and EAT in diabetic patients.
Methods: This was a cross-sectional study involving 156 patients with type 2 diabetes mellitus (87 females, 69
males; mean age, 53.62 ± 9.33 years) and 50 control subjects (35 females, 15 males; mean age, 51.06 ± 8.74 years).
EAT was measured by using a trans-thoracic echocardiogram. Atherogenic index of plasma was calculated as
the logarithmically transformed ratio of the serum triglyceride to high density lipoprotein (HDL)cholesterol. NLR
and PLR were calculated as the ratio of the neutrophils and platelets to lymphocytes, respectively.
Results: Waist circumference, PLR, NLR, AIP and EAT measurements were significantly higher in diabetic patients when
compared to control subjects. When diabetic patients were separated into two groups according to their median
value of EAT (Group 1, EAT < 4.53 (n = 78) and group 2, EAT ≥4.53 (n = 78)), group 2 patients had significantly
higher Body mass index (BMI), waist circumference, AIP, NLR and PLR levels. In the bivariate correlation analysis,
EAT was positively correlated with PLR, NLR, AIP, BMI and waist circumference (r = 0.197, p = 0.014; r = 0.229,
p = 0.004; r = 0.161, p = 0.044; r = 0.248, p = 0.002; r = 0.306, p < 0.001, respectively). Waist circumference was found
to be independent variables of EAT.
Conclusions: Simple calculation of PLR and measurement of waist circumference were found to be associated
with increased EAT in diabetic patients.
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Cardiovascular diseases remain the most common cause
of morbidity and mortality in diabetic patients [1].
Nowadays, beside the main factors including hyperten-
sion, obesity, and dyslipidemia, novel risk factors such
as chronic low-grade inflammation, advanced glycolisa-
tion end-products (AGE), oxidative stress and endothe-
lial dysfunction are accepted as the responsible factors
to highlight this increased cardiovascular risk in this
population [2,3]. Epicardial adipose tissue (EAT), a
metabolically active visceral fat tissue located between
the heart and pericardium, has been proposed a novel
cardiovascular risk in general population [4]. In the past
years, high sensitive C-reactive protein (hs-CRP) was
the most commonly encountered marker for evaluating
inflammation. Recently, two novel inflammatory markers,
neutrophils-to-lymphocyte ratio (NLR) and platelet-to-
lymphocyte ratio (PLR), were demonstrated that these two
markers could predict inflammation as accurate as hs-
CRP in various disorders [5,6].
Anthropometric parameters are commonly used to
assess the risk factors in various metabolic disorders [7].
Previous studies have shown that anthropometric parame-
ters including waist circumference, body mass index, waist
hip ratio, and waist height ratio are useful measures for
predicting the incidence of type 2 diabetes mellitus in
different patient groups [8,9]. Logarithmic ratio of tri-
glycerides to HDL was defined as atherogenic index of
plasma (AIP) and this index was found to be closely as-
sociated with atherosclerosis in general population [10].
However, in the literature, data regarding the relation-
ship between anthropometric measures, PLR, NLR, AIP
and EAT in diabetic patients is scant. Hence, we aimed
to investigate the relationship between these parameters
and EAT. We also sought to determine the independent
variables of EAT in patients with type 2 diabetes mellitus




The study protocol was approved by the Medical Ethics
Committee of Erzincan University (School of Medicine,
Erzincan, Turkey). Written informed consent was ob-
tained from all subjects included in the study. This was
a cross-sectional study involving 156 type 2 diabetic
patients (87 females, 69 males; mean age, 53.62 ± 9.33 years;
diabetes duration, 88.31 ± 75.35 months) and 50 control
subjects (35 females, 15 males; mean age, 51.06 ±
8.74 years).
Patients aged 18–80 years willing to participate were
screened. A review of medical records (including informa-
tion on age, sex, weight, height, disease duration, medica-
tions, history of other diseases, smoking) was undertaken.Exclusion criteria were infection, autoimmune disease,
and acute diabetic complications. One hundred and
sixty patients were evaluated and 4 patients excluded
from the study. Of these 4 patients, three patients had
active infection; and one patient had diabetic ketoacidosis.
The remaining 156 type 2 diabetic patients fulfilled the
above criteria and were enrolled in the study. Of these
156 patients, 29 patients were taking insulin and oral anti-
diabetics; 69 patients were taking only oral antidiabetics;
25 patients were taking only insulin and 33 patients were
not taking any antidiabetic medication.
Control subjects were chosen from metabolically healthy
individuals according to NCEP ATP III Metabolic syndrome
criteria (Two or less metabolic criteria; Blood pressure ≥130/
85 mmHg, TG ≥1.7 mmol/L, HDL-C: Men <1.03 mmol/L,
Women <1.30 mmol/L, Glucose ≥5.6 mmol/L, Waist cir-
cumference: Men <102 cm, Women < 88 cm) [11].
Biochemical analyses, data collection and procedures
The systolic blood pressure (SBP) and diastolic blood pres-
sure (DBP) of patients were measured in the upright sitting
position after >5 minutes of rest using an Erka sphygmo-
manometer (PMS Instruments Limited, Berkshire, UK)
with an appropriate cuff size. Two readings were recorded
for each individual. The mean value of two readings was
defined as the blood pressure. Patients who were already
on antihypertensive treatment (n = 70) or with SBP and
DBP >140 mmHg and 90 mmHg (seventeen patients with-
out taking any antihypertensive treatment) respectively
were assumed to be hypertensive.
Body-mass index (BMI) was calculated as body weight di-
vided by the square of the height. Waist circumference was
measured at the level of midway between the lower rib mar-
gin and iliac crest after removal of the clothes. Weight and
height was measured with the possible lightest clothing and
without shoes. Estimated glomerular filtration rate (eGFR)
was calculated according to Cockcroft-Gault formula [12].
Venous blood samples for biochemical analyses were
drawn after at least 10 hours of fasting before taking any
medication. All biochemical analyses were undertaken in
the Central Biochemistry Laboratory of the Erzincan Uni-
versity School of Medicine, Mengücek Gazi Training and
Research Hospital. Total cholesterol (TC), low density
lipoprotein cholesterol (LDL-C), high density lipoprotein
cholesterol (HDL-C) and plasma triglyceride concentra-
tions were undertaken using an oxidize-based technique
by the Beckman Coulter AU 2700 plus, Missima, Japan.
Hemoglobin A1c (HbA1c) was measured by HPLC
method using the Adams HA-8160 (Shiga, Japan). Serum
creatinine were measured with Jaffe Method.
Definition of PLR and NLR
Complete blood counts with automated differential
counts, which included total white blood cells, neutrophils,
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were calculated as the ratio of the neutrophils and
platelets to lymphocytes respectively, both obtained
from the same automated blood sample at the admis-
sion of the study.
Definition of atherogenic index of plasma
Atherogenic index of plasma was calculated as the loga-
rithmically transformed ratio of the serum triglyceride
to HDL-cholesterol [13].
Definition of epicardial adipose tissue thickness
All participants underwent transthoracic echocardiog-
raphy imaging using an echocardiograph equipped with a
broadband transducer (Vivid S4, GE Medical Systems,
USA). Measurements were obtained from the long axis
and apical four-chamber-view according to the standard
criteria. Echocardiograms were recorded on videotapes.
EAT appears as an echo-free space in the pericardial layers
on 2-D echocardiography. EAT thickness was measured
on the free wall of right ventricle at end-diastole from the
parasternal long- and short-axis views by two cardiologists
(E.M.B and H.H) blinded to clinical data. Measurements
from the parasternal long- and short-axis were averaged.
The echocardiograms of 20 patients were randomly se-
lected and a second measurement of the EAT was per-
formed 2 weeks later in order to assess the inter-observer
and intra-observer variability. The inter-observer and
intra-observer variabilities of the EAT were found as 3.4%
and 3.0%, respectively.
Statistical analysis
Statistical analyses were carried out using the Statistical
package for Social Sciences for Windows version 15.0
(SPSS, Chicago, IL, USA). Descriptive statistics for each
variable were determined. Results for continuous variables
were demonstrated as mean ± standard deviation. Stat-
istical significant difference between the groups was de-
termined by the chi-square test for categorical variables
and unpaired Student t test for continuous variables.
Associations between the variables were explored using
the Pearson correlation and Spearman’s rho (for data
that were not normally distributed). Logistic regression
analysis with backward elimination was also performed
to define variables associated with EAT. A p value less
than 0.05 was considered significant.
Results
Baseline characteristics of patients
The baseline characteristics of 156 DM patients and 50
control subjects were shown in Table 1. There were no
differences with respect to the following variables between
diabetic patients and control subjects, age, gender, BMI,
waist circumference, DBP, serum levels of triglyceride, TC,LDL-C and eGFR. Control group had significantly lower
HbA1c, SBP, serum creatinine, AIP, EAT, NLR and PLR
levels while HDL-C and uric acid levels were significantly
higher in this group.
Evaluation of PLR, NLR, AIP and EAT
Platelet-to-lymphocyte ratio, NLR, white blood count
(WBC) and neutrophil levels were significantly higher in
diabetic patients when compared to control group
(Table 1). Absolute lymphocyte and platelet counts had
no significant difference (p > 0.05). When diabetic patients
were separated into two groups according to their median
value of EAT (Group 1, EAT < 4.53 (n = 78) and group 2,
EAT ≥4.53 (n = 78)), there were no differences with re-
spect to the following variables between these two groups;
age, gender, HbA1c, disease duration, SBP, DBP, serum
levels of triglyceride, TC, LDL-C, creatinine, uric acid and
eGFR (Table 2). Group 2 patients had significantly higher
BMI, waist circumference, AIP, NLR and PLR levels
while HDL-C levels were significantly lower in this
group (Table 2).
Correlation analysis
In the bivariate correlation analysis in diabetic patients,
EAT was positively correlated with PLR, NLR, AIP, BMI
and waist circumference (Table 3). Atherogenic index of
plasma was positively correlated with HbA1c and waist
circumference (r = 0.197, P = 0.014 and r = 0.159, P = 0.048
respectively).
We also performed logistic regression analysis to define
the variables of EAT (Table 4). Age, duration of diabetes,
age, waist circumference, BMI, systolic blood pressure,
hemoglobin A1C, uric acid, LDL-cholesterol, AIP, NLR
and PLR were included in this model. Waist circumfer-
ence was found to be independent variables of EAT.
Discussion
There were five main findings of the present study. First,
inflammation markers including PLR and NLR were sig-
nificantly increased in diabetic patients when compared
with control group. Second, AIP and EAT measurements
were found to be increased in diabetic patients compared
to control subjects. Third, AIP, NLR and PLR were signifi-
cantly high in patients with higher EAT. Forth, EAT was
positively correlated with PLR, NLR, BMI, waist circum-
ference and AIP. Lastly, only waist circumference was
found to be independent predictors of increased EAT in
diabetic patients.
Chronic low-grade inflammation plays an important
role in increased cardiovascular morbidity and mortality
in patients with diabetes mellitus [14]. During the last
two decade, main importance of chronic inflammation
was highlightened with the improvements of defining
the pathogenesis of atherosclerosis in this population
Table 1 Demographic, clinic and laboratory features of the study groups
Parameters Diabetic patients (n = 156) Control group (n = 50) P value
Age (years) 53.62 ± 9.33 51.06 ± 8.74 0.080
Female/Male 87/69 35/15 0.980
BMI (kg/m2) 31.21 ± 5.87 32.86 ± 7.52 0.159
Waist circumference 103.24 ± 11.29 102.54 ± 11.28 0.702
HbA1c (%) 9.14 ± 2.45 5.50 ± 0.32 <0.001
Disease duration (months) 88.31 ± 75.35 - -
SBP (mmHg) 135.80 ± 26.97 121.80 ± 16.41 0.001
DBP (mmHg) 74.49 ± 11.43 75.60 ± 11.50 0.553
Total cholesterol (mmol/L) 5.49 ± 1.36 5.61 ± 1.47 0.616
Triglyceride (mmol/L) 2.35 ± 1.55 1.97 ± 1.03 0.052
LDL - cholesterol (mmol/L) 3.39 ± 1.12 3.66 ± 0.85 0.078
HDL - cholesterol (mmol/L) 1.1 ± 0.23 1.23 ± 0.22 <0.001
AIP 0.27 ± 0.30 0.16 ± 0.26 0.012
eGFR (mL/min) 116.76 ± 40.81 126.07 ± 42.42 0.177
Creatinin (mg/dL) 0.82 ± 0.36 0.73 ± 0.16 0.017
EAT (mm) 4.66 ± 1.59 3.91 ± 1.60 0.005
NLR 1.90 ± 0.82 1.45 ± 0.38 <0.001
PLR 116.67 ± 41.62 102.97 ± 35.97 0.027
White blood cell (103/μL) 7.42 ± 2.06 6.77 ± 1.58 0.022
Lymphocyte (103/μL) 2.43 ± 0.73 2.55 ± 0.71 0.296
Neutrophil (103/μL) 4.36 ± 1.59 3.57 ± 0.95 0.001
Platelet (103/mm3) 265.87 ± 67.82 247.52 ± 57.76 0.087
Uric acid (mg/dL) 4.68 ± 1.50 5.30 ± 1.44 0.010
AIP; Atherogenic index of plasma, BMI; body mass index, EAT; epicardial adipose tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-to-lymphocyte ratio.
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mation may cause endothelial dysfunction secondary to
decreasing vasodilatatory mediators including prostaglan-
dins and nitric oxide [15]. In one hand, this chronic
situation alters the vasodilatation-vasoconstriction steady
state which results in the deterioration of antiatherogenic
and antithrombotic properties of the endothelium. On the
other hand, hypertension may become prominent second-
ary to diminished NO levels regardless of other factors
that affects blood pressure levels in diabetic patients [16].
Inflammatory cytokines such as Tumor necrosis factor-α
(TNF-α), IL-1β and IL- 6 were found to play a central role
in the vicious circle of inflammation, endothelial dysfunc-
tion and atherosclerosis in patients with diabetic micro
and macrovascular complications [17,18]. Furthermore,
previous studies have suggested that chronic low grade
inflammation might play a major role in development of
insulin resistance, thus might further proceed to devel-
opment of overt diabetes mellitus [15].
Recent studies demonstrated that activated neutrophils
and platelets could be an important part of increased
atherogenesis especially in the era of inflammation com-
monly seen in chronic diseases [19-21]. Platelets caninteract with a variety of different cell types including
endothelial cells, dendritic cells, T-lymphocytes, neutro-
phils and mononuclear phagocytes. Additionally, recent
studies showed that the interactions of platelets with
these cells mentioned above might initiate and exacer-
bate the inflammation in the arterial wall [22]. There has
been an increasing evidence demonstrated that activated
platelets could incite leukocyte recruitment to the vessel
wall and trigger the inflammation that can mainly seen
in the pathogenetic mechanism of atherosclerosis [23].
As novel inflammation markers, PLR and NLR were in-
troduced in cardiac and non-cardiac disorders [5,24-30].
Moreover, NLR was shown to be related with cardiovascu-
lar morbidity and mortality in diabetic patients [31,32]. In
the present study, we found that diabetic patients had
higher levels of PLR and NLR than control subjects. This
might be attributable to increased inflammation in this
population.
Epicardial adipose tissue (EAT) originates from the
splanchnopleuric mesoderm [33]. Mazurek et al. [34]
concluded that, like abdominal visceral adipose tissue,
EAT is also metabolically active because it can secrete
proinflammatory cytokines and utilize free fatty acids
Table 2 Demographic, clinic and laboratory features of diabetic patients according to EAT groups
Parameters EAT < 4.53 (n = 78) EAT ≥ 4.53 (n = 78) P value
Age (years) 52.80 ± 9.39 54.44 ± 9.27 0.273
Female/Male 46/32 41/37 0.519
BMI (kg/m2) 30.18 ± 6.00 32.24 ± 5.59 0.028
Waist circumference 100.30 ± 11.36 106.19 ± 10.49 0.001
HbA1c (%) 9.12 ± 2.55 9.16 ± 2.35 0.922
Disease duration (months) 82.62 ± 72.75 94.00 ± 77.92 0.347
SBP (mmHg) 135.77 ± 26.57 135.83 ± 27.54 0.988
DBP (mmHg) 73.78 ± 9.58 75.19 ± 13.05 0.443
Total cholesterol (mmol/L) 5.46 ± 1.37 5.53 ± 1.35 0.731
Triglyceride (mmol/L) 2.12 ± 1.18 2.57 ± 1.83 0.068
LDL - cholesterol (mmol/L) 3.46 ± 1.15 3.33 ± 1.09 0.468
HDL - cholesterol (mmol/L) 1.16 ± 0.22 1.04 ± 0.24 0.002
AIP 0.21 ± 0.28 0.33 ± 0.30 0.010
eGFR (mL/min) 115.51 ± 38.70 118.00 ± 43.04 0.705
Creatinin (mg/dL) 0.78 ± 0.25 0.86 ± 0.45 0.145
EAT (mm) 3.52 ± 0.75 5.80 ± 1.37 <0.001
NLR 1.73 ± 0.69 2.08 ± 0.90 0.007
PLR 109.14 ± 38.06 124.20 ± 43.85 0.023
Uric Acid (mg/dL) 4.62 ± 1.42 4.74 ± 1.58 0.628
AIP; Atherogenic index of plasma, BMI; body mass index, EAT; epicardial adipose tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-to-lymphocyte ratio.
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EAT acts an extremely active organ that produces several
bioactive adipokines, as well as proinflammatory and
proatherogenic cytokines including tumor necrosis factor
(TNF)-α, interleukin (IL)-6, resistin, visfatin, omentin, lep-
tin, plasminogen activator inhibitor-1 (PAI-1) and angio-
tensinogen [4,34-37]. We recently showed that EAT is
increased in hemodialysis and peritoneal dialysis patients
[30,38] and this active visceral fat tissue is closely related
with malnutrion-inflammation-atherosclerosis/calcification
syndrome (MIAC) in dialysis patients [39].
Atherogenic index of plasma, measured as the loga-
rithmically transformed ratio of the serum triglyceride to
HDL-cholesterol, may reflect the actual composition of
the lipoprotein spectrum that might predict both the
cardiovascular risk and effectiveness of therapy especiallyTable 3 Bivariate correlation results between EAT and
other significant parameters in diabetic patients




BMI (kg/m2) 0.248 0.002
Waist circumference 0.306 <0.001
AIP; Atherogenic index of plasma, BMI; body mass index, EAT; epicardial adipose
tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-to-lymphocyte ratio.in cardiovascular disorders [13]. As an inexpensive re-
search tools, anthropometric parameters are commonly
used to assess the risk factors in various metabolic disor-
ders [7]. In this regard, previous studies have shown that
anthropometric parameters including waist circumfer-
ence, body mass index, waist hip ratio, and waist height
ratio are useful measures for predicting the incidence of
type 2 diabetes mellitus in different patient groups [8,9].
In the present study, we demonstrated that AIP and
EAT measurements were increased in diabetic patients
when compared with control subjects. Increased EAT
was found to be positively correlated with NLR, PLR,
BMI, waist circumference and AIP in patients with dia-
betes. AIP was significantly increased in diabetic patients
who have higher EAT volumes. This association might
be attributed to increased levels of proinflammatory cyto-
kines secreted by EAT. Studies have shown an important
association between obesity and cardiovascular morbidity
and mortality in diabetes patients [40].
Increased waist circumference, a sign of obesity, is
recognized as an important risk-factor for the develop-
ment of most features of metabolic syndrome, and has
been linked with all-cause mortality [41-43]. There is a
significant correlation between epicardial fat measured
by echocardiography and waist circumference [44,45].
Additionally; the relationship between waist circumfer-
ence, EAT and subclinical inflammation has been proven
[34-37,46-49]. However, a subset of obese individuals who
Table 4 Variables of epicardial adipose tissue
Parameters Standardized beta‡ t P value 95% CI
STEP 1
Age (years) 0.083 0.93 0.35 −0.016-0.44
Duration of diabetes (months) 0.115 1.35 0.17 −0.001-0.006
BMI (kg/m2) −0.110 −0.78 0.43 −0.105-0.046
Waist circumference (cm) 0.382 2.159 0.01 0.013-0.095
SBP (mmHg) −0.114 −1.324 0.18 −0.017-0.003
HbA1c (%) −0.032 −0.368 0.71 −0.132-0.091
Uric acid −0.012 −0.143 0.88 −0.193-0.167
LDL (mmol/L) 0.043 0.539 0.59 −0.004-0.007
AIP 0.093 1.106 0.27 −0.396-1.404
NLR 0.022 0.233 0.81 −0.315-0.399
PLR 0.117 1.287 0.20 −0.002-0.011
r2 = 0. 16
Adjusted r2 = 0.096
p = 0.007
STEP 10
PLR 0.141 1.867 0.06 0.000-0.011
Waist circumference (cm) 0.326 4.320 <0.0001 0.025-0.067
r2 = 0. 127
Adjusted r2 = 0.116
p < 0.0001
AIP; Atherogenic index of plasma, BMI; body mass index, CI; confidental interval, EAT; epicardial adipose tissue NLR; neutrophils-to-lymphocyte ratio, PLR; Platelet-
to-lymphocyte ratio.
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bances has been identified and called as “metabolically
healthy obese” [50]. Epicardial adipose tissue and PLR can
be used as inexpensive, non-invasive and simple tests in
the differentiation of metabolically healthy obese individ-
uals and metabolically unhealthy obese patients.
In this study, we demonstrated that waist circumference
and PLR were closely associated with EAT. In this regard,
one potential explanation is that, risk factors of diabetes
mellitus, such as obesity, smoking and physical inactivity
are associated with chronic low grade inflammation.
Hence, the results of the previous studies are in accord
with ours and this relation might be secondary to ongoing
systemic inflammation, obesity and diabetes mellitus.
Calculation of PLR and measurement of waist circum-
ference are quite simple and cheap methods when com-
pared other inflammatory cytokines including IL-6, IL-1β
and TNF-α. Our results confirm that PLR and waist
measurements might be related to increased EAT in
diabetic patients. Therefore, these simple, relatively in-
expensive and universally available methods can be used
by internists, nephrologists and other health care staff
for the first evaluation of inflammation and obesity in
patients with diabetes before applying other expensive
and invasive procedures.Iacobellis et al. [51] reported the echocardiographic
measurement of EAT for the first time. Measurement of
EAT with echocardiography were correlated with EAT
measurements by multislice computerized tomography
(MSCT) as well as anthropometric and metabolic parame-
ters [24,30]. Although many researchers advise measuring
EAT using MSCT, echocardiography is a simple and inex-
pensive method for EAT measurement. Hence we pre-
ferred using echocardiography to measure EAT.
Our study had three main limitations. First, this was a
cross-sectional analysis of diabetic patients focusing on
the relationship between PLR, NLR, AIP and EAT. Sec-
ond, the sample size was relatively small. Third, al-
though EAT has a three dimensional distribution, two
dimensional echocardiographic measurements may not
be enough to assess the total amount. This was not a
prospective controlled study, so we cannot draw cause-
and-effect relationships from our findings.
Conclusions
The relation between inflammation and adipose tissue is
extremely complex in diabetic patients. However, simple
calculation of PLR and measurement of waist circumfer-
ence can reveal inflammation and EAT in this population.
Further randomized and controlled studies evaluating the
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tissue in diabetic patients are needed.
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